Loading organizations...
Loading organizations...
Detects and tracks age-related macular degeneration to prevent blindness.
MacuLogix has raised $57.8M across 5 funding rounds.
MacuLogix has raised $57.8M in total across 5 funding rounds.
MacuLogix has raised $57.8M in total across 5 funding rounds.
MacuLogix's investors include Nathan Dau, Berwind Private Equity, Stephen Rose, Ron Thiboutot, Carole Nuechterlein, Jerry Michaud, Silicon Valley Bank, Mel Billingsley, Ben Franklin Technology Partners/CNP, Larry Norton, Life Sciences Greenhouse of Central Pennsylvania, Roche.
MacuLogix has raised $57.8M across 5 funding rounds. Most recently, it raised $38.7M Series D in March 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 4, 2019 | $38.7M Series D | Nathan Dau | Berwind Private Equity, Stephen Rose, Ron Thiboutot, Carole Nuechterlein |
| Aug 14, 2018 | $10.0M Debt | Jerry Michaud | Silicon Valley Bank |
| Jul 18, 2017 | $500K Other Equity | Mel Billingsley | |
| Jul 31, 2015 | $5.0M Other Equity | ||
| Mar 11, 2013 | $3.6M Series A | Ben Franklin Technology Partners/CNP, Larry Norton, Life Sciences Greenhouse of Central Pennsylvania, Roche |